240.a Improving access to living donor transplantation
Prof. Gabriel Oniscu, Sweden
240.1 Human Parvovirus B19 Infection in Kidney Transplant Recipients: Therapeutic Strategies and Outcomes.
Dr. Arun Panjathia, India
240.2 An observational, multicentre, nationwide study on practices and patterns of living-related kidney exchange transplantation in India
Sanshriti Chauhan, India
240.3 Post-kidney transplant (KTx) with primary allograft function, comparison of Serum creatinine with Serum Cystatin-C, and measured urinary creatinine clearance (mCrCl) with MDRD-4 eGFR and MDRD-4 eGFR eGFRCysC
Ashokkumar B Jain, United States
240.4 Initial eGFR Reduction as a Predictor of Kidney Function Following Living Kidney Donation: A Retrospective Analysis
Dr. Franco Cabeza Rivera, United States
240.5 Validation of the Toulouse-Rangueil eGFR12 Model in a Racially Diverse Retrospective Cohort
Dr. Daniel S Del Castillo Rix, United States
240.6 Live donor nephrectomy: Patient experience and COVID-19
Dr. Natalie M Edwards, United Kingdom
240.7 Ureterovesical leak following renal transplant and effects of acute rejection and antirejection therapy: A nested case-control analysis and outcome of 1102 consecutive renal transplant recipients
Akshay Kriplani, India
240.8 Pediatric kidney transplantation: A single center experience of 988 transplants from a low-income country
Dr. Abdul Khalique, Pakistan
240.9 Roles of renal volumetry and scintigraphy in living kidney transplant donors; contribution to early recovery of residual renal function
Dr. Kuniaki Inoue, Japan
240.10 Long-term follow-up of living kidney donors: A need for Indian Registry